Skip to main content

Publication, Part of

National Pulmonary Hypertension Audit 11th Annual Report

Audit, Open data

Summary

Pulmonary hypertension (PH) is a rare disease which occurs at any age, has many causes, and often shortens life expectancy. In the UK, seven hospitals are designated to diagnose and treat PH in adults, and one hospital for children. The National Audit of Pulmonary Hypertension is an audit of processes and outcomes and has the participation of all eight designated centres. The Audit uses national standards to measure clinical practice.

This 11th Annual Report includes 10 year survival curves for diagnostic groups and reference tables, as well as results against the National Standards. Other documents include: all tables and charts in Excel format, open data in CSV format and five years of National Standard aggregated data by PH centre.

This year performance against audit standards has been evaluated at a national rather than centre specific level due to the varied impact of COVID-19 across the UK and the effect this has had on individual PH centres. Therefore, the reader should focus on the national rather than local performance of centres.

This report was updated on February 2021.

Due to an error in the drug class mapping file used in version 1.0 of the 11th Annual Report, version 1.1 onwards reverted to the drug classes used in the 10th annual report. See the Glossary: PH Characteristics slide in the main report for details of how drug class is defined.

The following files have been updated to reflect these changes: • NAPH 11AR - Main Report (PowerPoint) v1.1.pptx • NAPH 11AR - Main Report v1.1.pdf • NAPH 11AR - Main Report - Tables and Charts (Excel) v1.1.xlsx • NAPH 11AR - Open Data v1.1.csv


  • All 8 specialist PH centres covering England, Scotland and Wales took part in the 2019-20 Audit.
  • At national level, 8 of the 11 established1 National Standards were met.
     



Last edited: 19 April 2021 12:26 pm